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USA. EAbstract—This prospective study evaluates the accuracy of virtual touch imaging quantification (VTIQ), a non-
invasive shear wave elastography method for measuring cervical lymph nodes (LN) stiffness in differentiating
benign frommalignant LN. The study evaluated 270 LN in 236 patients with both conventional B-mode ultrasound
and VTIQ shear wave elastography before fine-needle aspiration biopsy (FNAB). LN stiffness was measured as
shear wave velocity (SWV) in m/s. Surgical resection was advised for FNAB results that were not clearly benign.
Surgical pathology confirmed 54 malignant LN. The receiver operating curve (ROC) identified a single cut-off
value of 2.93 m/s as the maximum SWV for predicting a malignant cervical LN. The sensitivity and specificity
were 92.59% and 75.46%, respectively. Positive predictive value (PPV) was 48.54% and negative predictive value
(NPV) was 97.60%. LN stiffness measured by VTIQ–generated shear wave elastography is an independent predic-
tor of malignancy. (E-mail: azizi@wilmingonendo.com)  2016 The Authors. Published by Elsevier Inc. on
behalf of World Federation for Ultrasound in Medicine & Biology. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Assessment of cervical lymph nodes (LN) is essential in
patients with head and neck cancer because it predicts
prognosis and helps in selection of treatment options
(Ishii et al. 1991; Vassallo et al. 1992). B-mode
ultrasound (US) imaging is widely used for pre-
operative imaging of head and neck cancer (Choi et al.
2013).
Sonographic features of malignant LN include
cystic content, spherical shape, central vascularity and
calcification. Presence of fatty hilum suggests a benign
LN (Ahuja and Ying 2003; Ying and Ahuja 2003).
Papillary thyroid carcinoma (PTC) recurs most
frequently at the cervical LN, with a reported recurrence
rate of up to 31% in patients. Recent studies revealed that
regional LNmetastasis predicts lower survival rates (Jung
et al. 2015).ddress correspondence to: Ghobad Azizi, Wilmington Endocri-
, 1717 Shipyard Boulevard, Suite 220, Wilmington, NC 28403,
-mail: azizi@wilmingonendo.com
1273Strain and shear wave elastography investigate dif-
ferences in the mechanical properties of structures by
applying an external force and monitoring the deforma-
tion response. Low relative displacement is linked to
decreased elasticity and malignancy. This technology
has been integrated into conventional US machines
(Ianculescu et al. 2014; Krouskop et al. 1998).
Shear wave can quantify velocity and indirectly mea-
sure tissue stiffness. Virtual touch imaging quantification
(VTIQ) is capable of creating shear wave images and sub-
sequent tissue quantification in one display and allows for
identification of regions formeasurement of tissue stiffness
(Benson and Fan 2012). The use of VTIQ software in the
United States was approved by the FDA in June of 2013
(Bell 2013). For this manuscript we decided to use the
term VTIQ instead of a generic shear wave term because
of some specific features unique to this technology.
Principle of acoustic radiation force impulse
elastography
VTIQ is based on the principle of acoustic radiation
force impulse (ARFI) technology (Benson and Fan 2012).
1274 Ultrasound in Medicine and Biology Volume 42, Number 6, 2016Tissue is compressed using an acoustic push beam that is
focused at the region of interest (ROI) to maximize the
local displacement of tissue via the acoustic impulse.
In tissue, shear waves travel at a velocity of around 1–
10 m/s (Benson and Fan 2012). Using image-based local-
ization and proprietary implementation of ARFI technol-
ogy, the shear wave speed may be quantified in a precise
anatomic region focused on a ROI with a pre-defined
1.5 mm size provided by the system (Sporea et al. 2011).
The VTIQ image is a color-coded display of relative
shear wave velocities within the user-defined ROI super-
imposed onto a conventional B-mode US image. VTIQ is
capable of four discrete shear wave display maps: veloc-
ity, quality, travel time and displacement (Benson and Fan
2012). The quality map is particularly important to make
sure that the VTIQ image quality is appropriate. Several
publications have shown that certain disease processes,
including malignancy, can alter the elastic properties of
tissue (Benson and Fan 2012; Rosen et al. 2008;
Wellman et al. 1999).
OBJECTIVE
The purpose of this study was to assess the effective-
ness of shear wave elastography with VTIQ, alone and in
combination with other B-mode characteristics, in evalu-
ating the risk of malignancy in cervical LN in the setting
of a clinical endocrine practice specializing in thyroid
disorders.
METHODS
We prospectively evaluated 270 LN in 231 consecu-
tive patients fromMarch 28, 2013 to November 12, 2014.
Patients were referred for the following reasons: enlarged
cervical LN (90 LN in 76 patients); thyroid nodule (TN)
management where LN were found during US exam
before FNAB (97 LN in 86 patients); or a history of thy-
roid carcinoma (TC) when enlarged LN were diagnosed
during routine post-operative US exam (83 LN in 69 pa-
tients). All patients were evaluated clinically and with US
by a single practitioner with more than 16 y of experience
in thyroid and neck US, 8 mo experience using SWE
routinely before study and whose practice is enriched in
thyroid disorders. We selected LN based on US features
suspicious for malignancy, and if LN did not have worri-
some features, the largest LN was selected for analysis.
All LN $15 mm in maximal dimension were sampled
regardless of B-mode US features and when worrisome
B-mode features were present, LN $5 mm were bio-
psied. Our reference standard was the FNAB cytology
result or surgical pathology result when FNAB was un-
able to make a definitive diagnosis.
The Health Insurance Portability and Account-
ability Act compliant study protocol was approved bythe Institutional Review Board and patients were studied
both before and after the VTIQ technology was approved
by the FDA. The FNAB cytopathology result or surgical
result when available was considered the reference stan-
dard. The inclusion criteria were the presence of LN
greater than 5 mm requiring FNAB to exclude malig-
nancy and age 18 y or older. All patients gave written
informed consent. The exclusion criteria were non-
diagnostic biopsy sample who refused repeat FNAB,
atypical/inconclusive FNAB result without definitive
diagnosis of cancer or when patient refused recommen-
ded surgical resection to have final diagnosis.
Gender, age, and number of US determined LNwere
noted at the time of initial US examination.
The LN were evaluated for the following B-mode
characteristics: size (length and height), cystic content,
presence of a fatty hilum, calcifications and location in
the neck. The axis ratio is defined as the shortest measure-
ment divided by the longest measurement of the LN. LN
were placed into two groups based on an axis ratio $0.5
and,0.5.
For power Doppler vascular patterns LN were
divided into three groups: group 1 had no blood flow;
group 2 had peripheral blood flow only; and group 3
had central blood flow (with or without peripheral vascu-
larity). LN locations in the neck were classified as
anatomic levels 2, 3, 4, 5 and 6. Figure 1 shows neck level
classification based on American Joint Committee on
Cancer recommendations (Som et al. 2000).
Shear wave elastography
Conventional US exam and shear wave elastography
were performedwith SiemensACUSONS3000USsystem
(Siemens Medical Solution, Mountain View, CA, USA).
The B-mode features were recorded with an 18 LHD
probe. Based on the location of the LN and anatomy of
the neck,we used a frequency between 8–17MHz to assess
B-mode and vascularity features. Themajority of LNwere
assessed with a frequency between 12–15MHz. The shear
wave image was created and reproduced twice with a 9 L4
Multi-D probe. Shear wave velocity (SWV) measurement
was performed using VTIQ software (Siemens Medical
Solution, Mountain View, CA, USA). A small ROI box
was used to measure LN tissue velocity. The stiffest area
within the LN was measured twice, read 1 and 2, because
the ROI box is relatively small (1.5 mm in diameter).
The highest velocity was reported as the maximum SWV.
Velocitymeanwas defined as the averageof the twoLNve-
locity measurements. The elastography exam was the last
part of the US exam before FNAB.
Fine-needle aspiration biopsy procedure
Consent was obtained before performing the proce-
dure. FNAB was performed under sterile conditions with
Fig. 1. This figure shows American Joint Committee on Cancer
classification of cervical lymph nodes (LN). Level 1 LN are sub-
mental and sub-mandibular; level 2 LN are upper internal jugu-
lar chain nodes; level 3 LN are middle internal jugular chain
nodes; level 4 LN are lower internal jugular chain nodes; level
5 LN are spinal accessory chain nodes and transverse cervical
chain nodes; and level 6 LN are anterior cervical nodes (Som
et al. 2000).
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passes were made of each LN using 27-gauge needles.
Cytopathology was used to determine the presence of ma-
lignancy in the LN under investigation.Statistical analysis
The primary aim of the study is to examine SWVand
B-mode US to predict risk of malignancy. In this analysis
maximum SWV measurements were performed twice.
We included the following B-mode US features: axis ra-
tio, calcification, cystic content, vascularity and fatty hi-
lum. Bivariate associations of presence or absence of
cancer with key continuous variables and discrete vari-
ables were determined using Wilcoxon signed tests and
chi-squared tests, respectively. Multivariate logistic
regression was used to determine association of presence
of cancer for each of the above variables controlling for
age and gender. Receiver operating curve (ROC) was
used to examine an optimum shear value that produces
maximum sensitivity in predicting cancer. In addition,
sensitivity, specificity and negative and positive predic-tive values of three levels of shear in predicting cancer
is determined and each of the above predictors is
examined. Statistical significance was determined at
alpha of 0.05. Statistical analysis was conducted using
SAS 9.3 (SAS Institute Inc., Cary, NC, USA).RESULTS
Cytopathology and pathology
In this prospective study 277 LN in 236 patients
were eligible for inclusion. Five patients with seven LN
were excluded due to previously mentioned criteria.
FNAB cytopathology results of the 270 LN in 231 pa-
tients enrolled in this study are discussed below.
There were a total of 216 benign LN and 54 malig-
nant LN. For benign LN the mean size was
15.1 6 6.2 mm, and for malignant LN the mean size
was 16.3 6 7.3 mm. The majority of malignant LN
were metastatic TC. There were 39 LN with metastatic
TC: one medullary TC, three follicular variant of PTC
and 35 PTC. Fifteen malignant LN were related to other
malignancies: six LN were positive for small cell lym-
phoma, five LN were metastatic squamous cell carci-
noma, two LN were associated with chronic
lymphocytic leukemia (CLL) and two LN contained met-
astatic prostate cancer in the neck. In this study, all pa-
tients with FNAB indicating metastatic TC underwent
surgical resection. For the remaining 15 LN, FNAB was
either diagnostic for malignancy or inconclusive. Those
patients with inconclusive FNAB had surgical resection
to make a final diagnosis.
See Figure 2 for examples of VTIQ display modes,
including shear wave elastography image, velocity mea-
surement and quality map. Figures 3–5 show examples
of VTIQ used to diagnose malignant LN.Bivariate analysis
The bivariate associations of benign versus malig-
nant status of cervical LN with demographic, clinical var-
iables and US (B-mode and elastography) characteristics
are presented in Table 1.
The maximum SWV for the malignant LN was
(mean 6 SD) 3.96 6 0.96 m/s, which was significantly
greater than the maximum SWV of the benign LN
(2.71 6 0.65 m/s; p , 0.0001). The velocity mean of
the two measurements of the stiffest areas of the malig-
nant LN was significantly higher versus that of the benign
LN (3.83 6 0.9 m/s vs. 2.62 6 0.64 m/s; p , 0.0001).
There was no significant difference between velocity
read 1 and read 2 of the stiffest area among the benign
and malignant LN as shown in Table 1.
Among the demographic characteristics, patients
with malignant LN were older (49.95 6 15.74 y) than
those with benign LN (45.21 6 15 y; p , 0.0583).
Fig. 2. (a) B-mode image of a lymph node (LN) in the left neck level 4 measuring 12.73 7.33 8.2 mmwith an axis ratio
.0.5. (b) Qualitative shear wave image of the LN. (c) Qualitative and quantitative shear wave image of the same LN. The
maximum shear wave velocity measurements of the LN were 2.53 m/s and 2.49 m/s. (d) Quality image. The green color
represents a good image quality. Fine-needle aspiration biopsy for this LN was benign.
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$0.5 was more prevalent among the malignant LN group
with 29 LN (53.7%) versus 52 benign LN (24.7%;
p , 0.0001). Other B-mode US characteristics thatFig. 3. (a) Lymph node (LN) in the left neck level 3 measurin
contains fatty hilum. (b) Qualitative and quantitative shear wa
of the LN were 4.02 m/s and 3.47 m/s. Fine-needle aspiration
carcinoma. Surgical pathology confirmed the dshowed a statistical difference between malignant and
benign LN groups included the presence of calcifications
in malignant LN, which was higher than in the benign
group (nine LN [16.67%] versus five LN [2.31%];g 23 3 8.6 3 13 mm with an axis ratio ,0.5. This LN
ve image of the LN. Shear wave velocity measurements
biopsy of this LN was consistent with papillary thyroid
iagnosis of papillary thyroid carcinoma.
Fig. 4. (a) Lymph node (LN) in the left neck level 5 measuring 133 93 13 mm with an axis ratio.0.5. (b) Qualitative
and quantitative shear wave image of the LN. Shear wave velocity measurements of the LN were 5.74 m/s and 5.45 m/s.
Fine-needle aspiration biopsy of this LN was diagnostic for squamous cell carcinoma. Surgical pathology confirmed this
diagnosis.
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were malignant and four (1.85%) were benign
(p , 0.0001). Fatty hilum was present more frequently
in the benign group with 49 LN (22.69%) versus two ma-
lignant LN (3.7%; p , 0.0001). This feature was predic-
tive of benign LN.
While lack of blood flow was predictive of benign
LN, peripheral and central blood flow were predictive
of malignant LN. In the bivariate analysis, based on
anatomic locations, malignant LN associated with levels
2 and 4 reached statistical significance.Receiver operating curves
The ROC (Fig. 6) was used to determine the sensi-
tivity and specificity of the continuous variable of
maximum SWV to predict malignant LN. The area under
the curve for this model is 0.88 (95% confidence interval
[CI]: 0.82 and 0.93). Based on the ROC curve for SWV
predicting malignant LN, a single cut-off of 2.93 m/sFig. 5. (a) Lymph node (LN) in the left neck level 4 measuring
and quantitative shear wave image of the LN. Shear wave veloc
Fine-needle aspiration biopsy, flow cytometry and subsequent su
lymphomhad a sensitivity of 92.59%. The specificity, positive
predictive value (PPV) and negative predictive value
(NPV) were 75.46%, 48.54% and 97.6%, respectively.Lymph nodes categorized by maximum shear wave
velocity groups
We divided LN into three groups based on maximum
SWV after we analyzed our statistical result: reference
group 1 (0–2.6 m/s), reference group 2 (.2.6–#3.2 m/s)
and reference group 3 (.3.2 m/s). Reference group 1
had a total of 125 LN with 122 benign LN (97.60%) and
3 malignant LN (2.4%). In group 2, eight of 63 LN
(12.7%) were malignant and 55 (87.3%) were benign.
Group 3 had a total of 82 LN with 39 benign (47.56%)
and 43 malignant (52.44%).Multivariate analysis
Table 2 provides the age and gender adjusted logistic
regression of potential predictors of malignant LN.173 53 10 mm with an axis ratio.0.5. (b) Qualitative
ity measurements of the LN were 3.89 m/s and 4.00 m/s.
rgical pathology of this LNwas consistent with small cell
a.
Table 1. The bivariate associations of cancer status of
lymph nodes with demographic, clinical variables and
ultrasound characteristics
Variable
No cancer n (%),
mean (SD)
(N 5 216)
Cancer n (%),
mean (SD)
(N 5 54) p Value
Age 45.21 (15) 49.95 (15.74) 0.0583
Female 157 (72.69) 28 (51.85) 0.0032
LN SWV read 1 2.61 (0.63) 3.86 (0.92) ,0.0001
LN SWV read 2 2.63 (0.66) 3.81 (0.91) ,0.0001
Maximum SWV 2.71 (0.65) 3.96 (0.96) ,0.0001
Mean SWV 2.62 (0.64) 3.83 (0.9) ,0.0001
Axis ratio $0.5 52 (24.07) 29 (53.7) ,0.0001
Calcifications 5 (2.31) 9 (16.67) ,0.0001
Cystic LN 4 (1.85) 12 (22.22) ,0.0001
Fatty hilum 49 (22.69) 2 (3.7) 0.0014
Power Doppler group 1 201 (93.06) 33 (61.11) ,0.0001
Power Doppler group 2 8 (3.7) 7 (12.96) 0.0079
Power Doppler group 3 7 (3.24) 14 (25.93) ,0.0001
Level 2 9 (4.17) 8 (14.81) 0.0040
Level 3 62 (28.7) 13 (24.07) 0.4969
Level 4 86 (39.81) 9 (16.67) 0.0014
Level 5 25 (11.57) 10 (18.52) 0.1742
Level 6 34 (15.74) 14 (25.93) 0.0800
LN 5 lymph nodes; SD 5 standard deviation; SWV 5 shear wave
velocity.
Table 2. Multivariate predictors of cancer adjusted for
age and gender
Variable
Odds
ratio
95% Lower
confidence
interval
95% Upper
confidence
interval
Fatty hilum vs. reference 0.186 0.042 0.820
Calcification vs. reference 20.433 4.998 83.538
Axis ratio $0.5 (reference: ,0.5) 2.855 1.390 5.866
Cystic vs. reference 18.607 4.720 73.355
Power Doppler
Group 1: (reference) no blood flow
Group 2: peripheral blood flow 5.222 1.539 17.721
Group 3: central blood flow 14.216 4.827 41.866
SWV Max
Group 1 (reference: 0–2.6)
Group 2: .2.6–#3.2 5.482 1.356 22.165
Group 3: .3.2 31.431 8.937 110.537
SWV 5 shear wave velocity.
1278 Ultrasound in Medicine and Biology Volume 42, Number 6, 2016Calcification (OR [95% CI]: 20.433 [4.998 and 83.538]),
an axis ratio $0.5 (OR [95% CI]: 2.855 [1.390 and
5.866]) and a cystic LN content (OR [95% CI]: 18.607
[4.720 and 73.355]) are predictive of malignant LN,
while the presence of fatty hilum (OR [95% CI]: 0.186
[0.042 and 0.820]) is predictive of benign LN.Fig. 6. A receiver operating curve shows shear wave velocity
predicting malignant lymph nodes. Intersections of the yellow
line with the curve are the points of highest sensitivity
(92.59%) and specificity (75.46%).As indicated previously, maximum SWV was
divided into three groups. Compared with the reference
group (0–2.6 m/s), the SWV group 2 (.2.6–#3.2; OR
[95% CI]: 5.482 [1.356 and 22.165]) and group 3
(SWV .3.2) (OR [95% CI]: 31.431 [8.937 and
110.537]) were predictive of malignant LN. The odds
of predicting malignancy compared to the reference
group progressively increased with higher SWV.
Power Doppler (PD) groups were also included in
this analysis. When using the PD group 1 as the reference
group, PD group 2 (OR [95% CI]: 5.222 [1.539 and
17.721]) and PD group 3 (OR [95% CI]: 14.216 [4.827
and 41.866]) were predictive of malignancy.
Neck levels that were statistically significant in
bivariate (levels 2 and 4) did not quite reach statistical sig-
nificance in multivariate analysis as a predictor of
malignancy.Sensitivity and specificity
In single cut-off analysis for predicting malignancy,
LN with maximum SWV $2.93 m/s had the best sensi-
tivity of 92.59%. The specificity, PPV and NPV were
75.46%, 48.54% and 97.6%, respectively. For the highest
SWV group (.3.2 m/s) the prevalence of malignant LN
was 52.44% with a sensitivity, specificity, PPV and
NPV of 79.63%, 81.94%, 52.44% and 94.15%, respec-
tively. Table 3 shows the sensitivity, specificity, PPV
and NPV for each respective SWV group, B-mode char-
acteristics and power Doppler.Maximum shear wave velocity of lymph nodes in
sub-group
In this sub-group analysis, we divided patients based
on their reason for referral. In the group of patients who
were referred for enlarged LN, there were 19 malignant
LN with a mean SWVof 4.35 6 1.22 m/s and 71 benign
Table 3. Sensitivity, specificity and positive and negative predictive values for predicting malignant lymph nodes for various
cut-offs of maximum shear wave velocity and B-mode characteristics
Value of maximum velocity (m/s) predicting malignant LN Sensitivity Specificity PPV NPV
$2.93 vs. ,2.93 (reference ,2.93) 50/54 (92.59%) 163/216 (75.46%) 50/103 (48.54%) 163/167 (97.60%)
.3.2 vs. #3.2 (reference #3.2) 43/54 (79.63%) 177/216 (81.94%) 43/82 (52.44%) 177/188 (94.15%)
B-Mode characteristics predicting malignant LN
Axis ratio 29/54 (53.70%) 164/216 (75.93%) 29/81 (35.80%) 164/189 (86.77%)
$0.5 vs. ,0.5
Calcification 9/54 (16.67%) 211/216 (97.69%) 9/14 (64.29%) 211/256 (82.42%)
Yes vs. no
Cystic content 12/54 (22.22%) 212/216 (98.15%) 12/16 (75%) 212/254 (83.46%)
Yes vs. no
Power Doppler 14/47 (29.79%) 201/208 (96.63%) 14/21 (66.67%) 201/234 (85.90%)
Group 3 vs. group 1
Fatty hilum predicting malignant LN 2/54 (3.70%) 167/216 (77.31%) 2/51 (3.92%) 167/219 (76.26%)
Fatty hilum predicting benign LN 52/54 (96.3%) 49/216 (22.69%) 49/51 (96.08%) 52/219 (23.74%)
LN 5 lymph nodes; NPV 5 negative predictive value; PPV 5 positive predictive value.
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tients referred for TN where LN was found during routine
exam, there were 17 malignant LN with a mean SWVof
3.69 6 0.48 m/s and 80 benign LN with a mean SWVof
2.56 6 0.51 m/s. In the last group of patients with a his-
tory of TC who had routine post-operative neck US, there
were 18 malignant LN with a mean SWV of
3.81 6 0.84 m/s and 65 benign LN with a mean SWV
of 2.79 6 0.77 m/s. SWV for all benign LN was very
similar.Maximum shear wave velocity of malignant lymph
nodes groups
In an additional sub-group analysis of the 54 malig-
nant LN, there were 39 LN with metastatic TC. The mean
SWV 6 SD for this group was 3.88 6 0.85 m/s. Among
LN with small cell lymphoma and CLL, the mean SWV
was 3.47 6 0.90 m/s. LN with metastatic squamous cell
carcinoma had the highest mean SWV of 5.40 6 0.81
m/s. Finally, the two LN with prostate cancer had a
mean SWVof 4.65 6 0.15 m/s.DISCUSSION
The purpose of this prospective study was to eval-
uate the performance of VTIQ generated SWV for pre-
dicting the risk of malignancy in cervical LN in patients
presenting to a clinical thyroid practice. Tissue stiffness
was assessed by creating shear wave images and subse-
quent tissue quantification in one display. The tissue ve-
locity is measured in m/s and directly correlates with
tissue stiffness.
Based on the ROC curve, the best single cut-off
maximum SWV for predicting malignant LN was
2.93 m/s with a sensitivity of 92.59%. The specificity,
PPV and NPV were 75.46%, 48.54% and 97.6%, respec-
tively. Compared with B-mode US features for predictingmalignancy, maximum SWV has a higher sensitivity and
a higher NPV that are likely to be clinically useful.
In a second analysis, LN were divided into three pre-
determined groups based on maximum SWV. In group 3,
with the highest SWV .3.2 m/s (OR [95% CI]: 31.431
[8.937 and 110.537]), 52.44% of LN (43 of 84 LN)
were malignant. When we compared these two cut-offs,
the ROC curve (2.93 m/s) had a better sensitivity and
NPV, while the .3.2 m/s cut-off had a better specificity
and PPV. In group 1 (SWV 0–2.6 m/s), 2.40% of LN
(3 of 125 LN) were malignant and 97.6% were benign.
Both the multi cut-off and single cut-off were effective
in distinguishing benign from malignant LN. A larger
study is required to validate or establish a single or multi
cut-off SWV to determine the risk for malignancy in cer-
vical LN. In a pilot study of 55 cervical LN performed
with Supersonic US, Bhatia et al. (2012) demonstrated
that SWV in malignant LN was higher than in benign LN.
B-mode US characteristics of benign and malignant
LN observed in this study are similar to those described
by others. B-mode features suggestive of malignancy
include an LN axis ratio $0.5, cystic content, calcifica-
tion and vascularity (Ahuja and Ying 2002, 2003;
Bhatia et al. 2011; Tohnosu et al. 1989; Vassallo et al.
1993; Ying and Ahuja 2003; Ying et al. 1996).
In our study, B-mode US LN characteristics of cystic
content and calcifications predicted malignant LN with a
high specificity of 98.1% and 97.69%, respectively. How-
ever, these features are not common, so the sensitivity
was low. The sensitivity of predicting cancer for cystic
content and calcification was 22.22% and 16.67%,
respectively. In this study, calcification in malignant LN
was associated only with metastatic PTC and was not pre-
sent with other malignant LN. Other studies reported this
finding as well (Som 1987, 1992).
Since worrisome B-mode features for LN, like calci-
fication and cystic content, are uncommon, an axis ratio
$0.5 is presently the most common B-mode feature
1280 Ultrasound in Medicine and Biology Volume 42, Number 6, 2016that distinguishes benign and malignant LN. We had 81
LN with an axis ratio $0.5 (OR [95% CI]: 2.855 [1.390
and 5.866]); 52 were benign and 29 were malignant.
Lack of vascularity is predictive of benign LN
(p , 0.0001). Both peripheral and central vascularity
are predictive of malignancy, with the latter being a stron-
ger predictor. Other publications reported the association
of peripheral and central vascularity with malignant LN
(Ahuja et al. 1997; Dragoni et al. 1999; Na et al. 1997;
Steinkamp et al. 1998).
The presence of fatty hilum is, in general, predictive
of benign LN (Rubaltelli et al. 1990; Solbiati et al. 1992).
In this study, 51 LN contained fatty hilum. Among this
group, two LN were malignant and 49 were benign.
This B-mode characteristic has a high sensitivity, but a
low specificity and NPV for predicting benign cervical
LN.
In this study, location of an LN in the neck based on
anatomic classification level (2, 3, 4, 5 or 6) was not a pre-
dictor for malignancy in the multivariate analysis.
The SWV for benign LN was very similar regardless
of their reason for referral. SWV for malignant LN was
higher when patients were referred for enlarged LN, but
did not reach statistical significance.
In this study, LN with squamous cell carcinoma had
the highest maximum SWV followed by prostate cancer,
TC and small cell lymphoma and CLL. A larger study
may be needed to examine the difference in SWVamong
metastatic LN. Thirty-nine of 54 malignant LN were met-
astatic TC. Twenty-seven of these malignant LN were
diagnosed before thyroid surgery while the remaining
12 were diagnosed during routine post-operative moni-
toring. This data demonstrates that this technology can
be helpful both pre- and post-operative when combined
with B-mode.
We did not analyze the performance of VTIQ with
thyroglobulin washout. The purpose of this study was
to compare the performance of non-invasive LN evalua-
tions. In addition, thyroglobulin washout is useful only
when evaluating for TC and would have missed all re-
maining malignant LN.
The strengths of this study include the prospective
design and large number of LN evaluated.
Limitations of virtual touch imaging quantification
Several factors may alter the SWVor make measure-
ment difficult. LN deeper than 4 cm are difficult to eval-
uate, as are LN in patients with thick or short necks. Close
posterior proximity to large vasculature can limit evalua-
tion due to motion artifact. Evaluation of LN near the tra-
chea, the posterior aspect of thyroid gland and at level 6
can be challenging. LN with a large or thick hilum can
show higher SWV as well. A larger multicenter trial
may be needed to validate our findings.Finally, since not all enlarged cervical LN were
sampled, there may have been a selection bias. This is a
limitation of almost all FNAB studies.CONCLUSION
In summary, in a single cut-off analysis, the best
SWV predicting malignancy in cervical LN is 2.93 m/s
with a sensitivity of 92.59%. The specificity, PPV and
NPV were 75.46%, 48.54% and 97.6%, respectively.
In a multi cut-off analysis, the rate of malignant LN
in the group with highest SWV (.3.2 m/s) was 52.44%.
The lowest SWV group (0–2.6 m/s) had a rate of 2.40%
for malignant LN and 97.60% rate for benign LN.
We conclude that LN stiffness measured by VTIQ–
generated quantitative shear wave elastography is an in-
dependent predictor of malignant LN. Our data suggest
that application of shear wave elastography may decrease
the number of FNAB for low risk LN and improve the
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